Letter to CMS - Payment Models for CAR-T Cell Therapy
Recent Advocacy Activity from the ASBMT
This month, the ASBMT sent three letters of importance to the Centers for Medicare & Medicaid Services.
Below are links to the letters.
ASBMT Commentary on CY2018 Proposed Changes to Physician Fee Schedule
CMS Payment Models for Chimeric Antigen Receptor T Cell (CAR-T) Therapy
ASBMT Concerns with Proposed Changes to Outpatient Reimbursement Policies